Berlin: The German government said Monday it is taking a 23% stake in CureVac, a German company working on a potential vaccine for the coronavirus, underlining its determination to keep key industries in the country.The state-owned KfW development bank will buy 300 million euros ($337 million) in CureVac shares, Economy Minister Peter Altmaier said, adding that the aim is to give CureVac “financial security."He said the government won't exert influence on CureVac's business decisions.
The main shareholder in CureVac is Dietmar Hopp, the co-founder of German-based business software company SAP.“For me and for the whole German government, it is ...